相似文献
1
Branch retinal vein occlusion associated with quetiapine fumarate.
BMC Ophthalmol. 2011 Aug 25;11:24. doi: 10.1186/1471-2415-11-24.
2
The role of quetiapine in the treatment of bipolar disorder.
Expert Opin Pharmacother. 2006 May;7(7):929-40. doi: 10.1517/14656566.7.7.929.
3
Use of quetiapine in bipolar disorder: a case series with prospective evaluation.
Int Clin Psychopharmacol. 2004 May;19(3):173-4. doi: 10.1097/00004850-200405000-00010.
4
Acute dystonia with quetiapine.
Clin Neuropharmacol. 2000 Jul-Aug;23(4):229-30. doi: 10.1097/00002826-200007000-00013.
5
Quetiapine: a review of its use in the treatment of bipolar depression.
Drugs. 2007;67(7):1077-95. doi: 10.2165/00003495-200767070-00008.
6
Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.
Drugs. 2005;65(17):2533-51. doi: 10.2165/00003495-200565170-00008.
7
Quetiapine: a review of its use in the management of bipolar depression.
CNS Drugs. 2012 May 1;26(5):435-60. doi: 10.2165/11203840-000000000-00000.
8
[Sustained leukopenia probably related to quetiapine].
Braz J Psychiatry. 2005 Dec;27(4):346. doi: 10.1590/s1516-44462005000400022. Epub 2005 Dec 12.
9
Quetiapine alone and added to a mood stabilizer for serious mood disorders.
J Clin Psychiatry. 2001 Sep;62(9):728-32. doi: 10.4088/jcp.v62n0911.
10
Severe hyperlipidemia associated with olanzapine and quetiapine use.
Am J Psychiatry. 2007 Oct;164(10):1614-5. doi: 10.1176/appi.ajp.2007.07020253.
引用本文的文献
1
Characteristics of eye disorders induced by atypical antipsychotics: a real-world study from 2016 to 2022 based on Food and Drug Administration Adverse Event Reporting System.
Front Psychiatry. 2024 Aug 2;15:1322939. doi: 10.3389/fpsyt.2024.1322939. eCollection 2024.
2
COVID-19 and Antipsychotic Therapy: Unraveling the Thrombosis Risk.
Int J Mol Sci. 2024 Jan 9;25(2):818. doi: 10.3390/ijms25020818.
3
Quetiapine-induced raised intra-ocular pressure: An unusual entity.
Indian J Psychiatry. 2023 Jun;65(6):708-710. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_80_23. Epub 2023 Jun 19.
4
Central retinal vein occlusion in a patient using the antipsychotic drug olanzapine: a case report.
J Med Case Rep. 2021 May 29;15(1):307. doi: 10.1186/s13256-021-02865-8.
5
Quetiapine associated Central Serous Chorioretinopathy: Implicit role of serotonin and dopamine pathways.
Indian J Ophthalmol. 2019 Feb;67(2):292-294. doi: 10.4103/ijo.IJO_929_18.
6
Central Retinal Vein Occlusion in 2 Patients Using Antipsychotic Drugs.
Case Rep Ophthalmol. 2017 Jul 26;8(2):410-415. doi: 10.1159/000479219. eCollection 2017 May-Aug.
本文引用的文献
1
Young patients with branch retinal vein occlusion: a review of 60 cases.
Retina. 2010 Oct;30(9):1520-3. doi: 10.1097/IAE.0b013e3181e79872.
2
Metabolic effects of the atypical antipsychotics.
South Med J. 2007 Aug;100(8):771-2. doi: 10.1097/SMJ.0b013e318063e8ef.
3
Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts.
Ophthalmology. 2007 Mar;114(3):520-4. doi: 10.1016/j.ophtha.2006.06.061. Epub 2006 Nov 30.
4
Hyperlipidemia following treatment with antipsychotic medications.
Am J Psychiatry. 2006 Oct;163(10):1821-5. doi: 10.1176/ajp.2006.163.10.1821.
5
Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study.
Arch Ophthalmol. 2006 May;124(5):726-32. doi: 10.1001/archopht.124.5.726.
6
Early response of neurons and glial cells to hypoxia in the retina.
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1126-41. doi: 10.1167/iovs.05-0518.
7
Consensus development conference on antipsychotic drugs and obesity and diabetes.
Diabetes Care. 2004 Feb;27(2):596-601. doi: 10.2337/diacare.27.2.596.
Zotero 插件
